| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SNTI | Common Stock | Award | $0 | +306,000 | +55% | $0.000000 | 865,496 | 01 Feb 2024 | Direct | F1 |
| holding | SNTI | Common Stock | 528,390 | 01 Feb 2024 | By spouse | ||||||
| holding | SNTI | Common Stock | 528,390 | 01 Feb 2024 | See footnote | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SNTI | Stock Option (Right to Buy) | Award | $0 | +459,000 | $0.000000 | 459,000 | 01 Feb 2024 | Common Stock | 459,000 | $0.4600 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. |
| F2 | The shares are held by Luminen Services, LLC, as trustee of the Luminen Trust, of which the reporting person is the settlor. The reporting person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. |
| F3 | The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. |